Press Release

David Thomas Inducted as a Fellow of the American College of Employee Benefits Counsel

Issued by Wilson Sonsoni

Sept. 28, 2022

Wilson Sonsini employee benefits and compensation partner David Thomas was recently inducted as a Fellow of the American College of Employee Benefits Counsel (ACEBC), a national distinction for employee benefits lawyers who have made demonstrably substantive contributions to the field of employee benefits over their entire career.

David was one of 17 new Fellows selected nationwide and honored at ACEBC’s 23^rd Annual Meeting and Induction Ceremony on September 17, 2022. Each nominee is required to have focused on employee benefits law for at least 20 years and have a sustained commitment to public awareness and understanding of benefits laws through such activities as writing, speaking, public policy analysis, public education, or public service. Nominees are also required to have provided exceptionally high-quality professional services to clients, the bar, and the public. The inductees join over 400 current Fellows in the organization.

“The College is honored to add this group of superb lawyers as new Fellows. Their sustained excellence and service to the employee benefits community and the public exemplifies what the College was created to recognize,” said ACEBC president Mark Bodron of Lumen Technologies, Inc.

ACEBC is a not-for-profit organization whose mission statement is: “Fostering excellence in the practice of employee benefits law and advancing public understanding of employee benefits.” The College advances its mission by encouraging the study and development of employee benefits laws and of significant legal and social policy issues impacting the regulation and management of pension, retirement, group health, welfare, and disability plans.

For more information, including a list of the newly elected Fellows, please see ACEBC’s news release.

Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink.